Cindy I. Mendes

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Mitochondrial Energy Metabolism in Cancer, Immunoregulation and Antitumour Response.

Mitochondrial Energy Metabolism in Cancer, Immunoregulation and Antitumour Response.

Journal: Advances in experimental medicine and biology

Published: July 11, 2026

Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges.

Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges.

Journal: Advances in experimental medicine and biology

Published: July 11, 2026

Metabolism-Driven Modulation by the Human Microbiota: Implications for Cancer Therapy and Emerging Strategies.

Metabolism-Driven Modulation by the Human Microbiota: Implications for Cancer Therapy and Emerging Strategies.

Journal: Advances in experimental medicine and biology

Published: July 11, 2026

Glucose and Lactate, Starters or Intermediates of Cancer Metabolic Rewiring.

Glucose and Lactate, Starters or Intermediates of Cancer Metabolic Rewiring.

Journal: Advances in experimental medicine and biology

Published: July 11, 2026

Metabolic reprogramming and molecular crosstalk at the cancer-endothelial interface in ovarian carcinoma.

Metabolic reprogramming and molecular crosstalk at the cancer-endothelial interface in ovarian carcinoma.

Journal: Molecular cancer

Published: March 06, 2026

Polycationic dendrimers synergizes with gefitinib to overcome EGFREx19Del-driven resistance in non-small-cell lung cancer.

Polycationic dendrimers synergizes with gefitinib to overcome EGFREx19Del-driven resistance in non-small-cell lung cancer.

Journal: Discover oncology

Published: September 04, 2025

Metabolism-targeted therapy in NSCLC - A new theranostics inhalation approach using lactate functionalized and selenium-chrysin loaded nanoparticles (SeChry@PUREG4-LA24).

Metabolism-targeted therapy in NSCLC - A new theranostics inhalation approach using lactate functionalized and selenium-chrysin loaded nanoparticles (SeChry@PUREG4-LA24).

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 29, 2025

Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting.

Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting.

Journal: Molecules (Basel, Switzerland)

Published: May 07, 2025

Targeting TNBC: core-shell polycationic polyurea dendrimers with inherent anticancer activity.

Targeting TNBC: core-shell polycationic polyurea dendrimers with inherent anticancer activity.

Journal: FEBS open bio

Published: March 17, 2025

Fatty acid and cysteine metabolic interplay regulate ferroptosis and highlight xCT as a selenium-chrysin target in breast carcinoma.

Fatty acid and cysteine metabolic interplay regulate ferroptosis and highlight xCT as a selenium-chrysin target in breast carcinoma.

Journal: The Journal of pathology

Published: September 12, 2024

Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells.

Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells.

Journal: Bioscience reports

Published: June 12, 2024

H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine.

H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine.

Journal: Antioxidants (Basel, Switzerland)

Published: December 05, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026